Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "Obesity"
Home
JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide
JW Pharmaceutical announced on Aug. 18 that it has submitted an Investigational New Drug application to South Korea’s Ministry of Food and Drug...
08/22/2026, 20:13 ET
Weight Unchanged but Waistband Tight? 5 Warning Signs of Rising Visceral Fat
If your overall weight remains stable but your stomach noticeably protrudes and your waistband feels tight, internal body fat may be quietly...
08/09/2026, 04:41 ET
Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care
Hanmi Pharmaceutical has officially named its in-development obesity treatment "EPPE.
08/03/2026, 09:55 ET
Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival
Olix announced on July 30 that its obesity drug candidate, "OLX501A," significantly outperformed a global rival...
08/02/2026, 06:52 ET
Depressive Symptoms Linked to Higher Fatty Liver Risk in Young Adults
Young adults in South Korea who experience depressive symptoms face roughly twice the risk of developing fatty liver...
07/30/2026, 20:45 ET
Does Sugar Always Raise Cancer Risk? An Oncologist Explains What Really Matters
Many people feel an immediate wave of guilt when faced with a sweet dessert. In particular, the widespread belief that...
07/27/2026, 05:31 ET
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven
Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.
07/27/2026, 05:31 ET
Samsung Biologics Bets 2.7 Trillion Won on Peptides in South Korea’s Largest Biotech M&A Deal
Samsung Biologics is making a major push into peptide-based medicines—widely used in weight-loss and diabetes...
07/22/2026, 03:25 ET
Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market
The glucagon-like peptide-1 (GLP-1) obesity treatment market, long dominated by subcutaneous injections, is rapidly...
07/20/2026, 19:27 ET
Maximizing Weight Loss vs. Protecting the Heart: The Paradox of Modern Anti-Obesity Drugs
As global demand for anti-obesity medications surges, a fierce pharmaceutical race is underway to develop...
07/14/2026, 08:17 ET
Previous
1
2
3
4
5
Next